Correlation of cytoplasmic β-catenin and cyclin D1 overexpression during thyroid carcinogenesis around Semipalatinsk nuclear test site

Thyroid

Volumn 13, Issue 6, 2003, Pages 537-545

  Meirmanov, Serik ^a   Nakashima, Masahiro ^a   Kondo, Hisayoshi ^a   Matsufuji, Reiko ^a   Takamura, Noboru ^a   Ishigaki, Katsu ^a   Ito, Masahiro ^b   Prouglo, Yuri ^c   Yamashita, Shunichi ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^c SEMEY MEDICAL UNIVERSITY   (Kazakhstan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; WNT PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DIAGNOSTIC TEST; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SEMIPALATINSK NUCLEAR TEST SITE; STATISTICAL SIGNIFICANCE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDITIS;

EID: 12444287602     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322238791     Document Type: Article

References (39)

1. Yamamoto M, Tsukatani T, Katayama Y 1996 Residual radioactivity in the soil of the Semipalatinsk nuclear test site in the former USSR. Health Phys 71:142-148.
2. Takada J, Hoshi M, Nagatomo T, Yamamoto M, Endo S, Takatsuji T, Yoshikawa I, Gusev BI, Sakerbaev AK, Tchaijunusova NJ 1999 External doses of residents near Semipalatinsk nuclear test site. J Radiat Res 40:337-344.
3. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ 1993 The epidemiology of thyroid carcinoma. Crit Rev Oncog 4:25-52.
4. Shore RE 1992 Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 131:98-111.
5. Yamashita S 1996 Proposal for establishment of screening of thyroid diseases around Semipalatinsk. Effects of low-level radiation for residents near Semipalatinsk nuclear test site. In: Hoshi M, Takada J, Kim R, Nitta Y (eds) Proceedings of the Second Hiroshima International Symposium, Hiroshima, July 23-25. Daigaku Letterpress Co., Ltd., Hiroshima, pp 225-234.
6. Zhumadilov Z, Gusev BI, Takada J, Hoshi M, Kimura A, Hayakawa N, Takeichi N 2000 Thyroid abnormality trend over time in northeastern regions of Kazakstan, adjacent to the Semipalatinsk nuclear test site: A case review of pathological findings for 7271 patients. J Radiat Res (Tokyo) 41:35-44.
7. Gusev BI, Rosenson RI, Abylkassimova ZN 1998 The Semipalatinsk nuclear test site: A first analysis of solid cancer incidence (selected sites) due to test-related radiation. Radiat Environ Biophys 37:209-214.
8. Alipov G, Ito M, Prouglo Y, Takamura N, Yamashita S 1999 Ret proto-oncogene rearrangement in thyroid cancer around Semipalatinsk nuclear testing site. Lancet 354:1528-1529.
9. Cadigan KM, Nusse R 1997 Wnt signaling: A common theme in animal development. Genes Dev 11:3296-3305.
10. Polakis P 2000 Wnt signaling and cancer. Genes Dev 14:1837-1851.
11. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P 1997 Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792.
12. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW 1997 Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790.
13. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H 1997 Constitutive transcriptional activation by a β-catenin-Tcf complex in APC -/- colon carcinoma. Science 275:1784-1787.
14. Tetsu O, McCormick F 1999 β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
15. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW 1998 Identification of c-myc as a target for the APC pathway. Science 281:1509-1512.
16. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P 1997 Stabilization of β-Catenin by genetic defects in melanoma cell lines. Science 275:1790-1792.
17. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu Y 1995 Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-Catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15:1175-1181.
18. Voeller H, Truica C, Gelmann E 1998 β-Catenin mutations in human prostate cancer. Cancer Res 58:2520-2523.
19. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y 1998 Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving Exon 3. Cancer Res 58:2524-2527.
20. Lin S-Y, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung M-C 2000 β-Catenin, a novel prognostic marker for breast cancer, its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97:4262-4266.
21. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G 2001 β-Catenin dysregulation in thyroid neoplasms - down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987-996.
22. Kurihara K, Shimizu S, Chong J, Hishima T, Funata N, Kashiwagi H, Nagai H, Miyaki M, Fukayama M 2000 Nuclear localization of immunoreactive β-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma. Jpn J Cancer Res 91:1100-1102.
23. Lazzereschi D, Sambuco I, Scalzo CC, Ranieri A, Mincione G, Nardi F, Colletta G 1998 Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int J Cancer 76:806-811.
24. Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, Hayashi T, Maeda S, Ichinose M, Kanematsu T, Yamashita S 2002 Aberrant localization of β-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87:3433-3440.
25. Nakashima M, Ito M, Ohtsuru A, Alipov GK, Matsuzaki S, Nakayama T, Yamashita S, Sekine I 1996 Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in giant cell tumour of tendon sheath. J Pathol 180:80-84.
26. Rocha AS, Soares P, Seruca R, Maximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simoes M 2001 Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 194:358-366.
27. Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L, Grieco M 1998 Beta- and gamma-catenin expression in thyroid carcinomas. J Pathol 185:267-272.
28. Helmbrecht K, Kispert A, von Wasielewski R, Brabant G 2001 Identification of a Wnt/β-catenin signaling pathway in human thyroid cells. Endocrinology 142:5261-5266.
29. Miyake N, Maeta H, Horie S, Kitamura Y, Nanba E, Kobayashi K, Terada T 2001 Absence of mutations in the β-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas. Pathol Int 51:680-685.
30. Orford K, Orford CC, Byers SW 1999 Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146:855-867.
31. Goto A, Sakamoto A, Machinami R 2001 An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Pathol Res Pract 197:217-222.
32. Wang S, Lloyd RV, Hutzler MJ, Safren MS, Patwardhan NA, Khan A 2000 The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 13:882-887.
33. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL 2002 Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 196:145-153.
34. Ryo A, Nakamura M, Wulf G, Liou Y-C, Lu KP 2001 Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nature Cell Biol 3:793-801.
35. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP 2001 Pinl is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 20:3459-3472.
36. Dubrova YE, Bersimbaev RI, Djansugurova LB, Tankimanova MK, Mamyrbaeva ZZh, Mustonen R, Lindholm C, Hulten M, Salomaa S 2002 Nuclear weapons tests and human germline mutation rate. Science 295:1037.
37. Testa A, Stronati L, Ranaldi R, Spano M, Steinhausler F, Gastberger M, Hubmer A, Ptitskaya L, Akhmetov M 2001 Cytogenetic biomonitoring carried out in a village (Dolon) adjacent to the Semipalatinsk nuclear weapon test site. Radiat Environ Biophys 40:125-129.
38. Stephan G, Pressl S, Koshpessova G, Gusev BI 2001 Analysis of FISH-painted chromosomes in individuals living near the Semipalatinsk nuclear test site. Radiat Res 155:796-800.
39. Tanaka K, Tchaijunusova NJ, Takatsuji T, Gusev BI, Sakerbaev AK, Hoshi M, Kamada N 2000 High incidence of micronuclei in lymphocytes from residents of the area near the Semipalatinsk nuclear explosion test site. J Radiat Res (Tokyo) 41:45-54.